Comparison of the efficacy in prevention of hepatitis B virus recurrence after liver transplantation between HBIG and lamivudine

Transplant Proc. 2001 Nov-Dec;33(7-8):3643-4. doi: 10.1016/s0041-1345(01)02567-2.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Antiviral Agents / therapeutic use
  • Combined Modality Therapy
  • Female
  • Follow-Up Studies
  • Hepatitis B / prevention & control*
  • Humans
  • Immunization, Passive
  • Immunoglobulins / therapeutic use*
  • Lamivudine / therapeutic use*
  • Liver Transplantation*
  • Male
  • Middle Aged
  • Postoperative Complications / prevention & control
  • Postoperative Complications / virology
  • Recurrence
  • Time Factors

Substances

  • Antiviral Agents
  • Immunoglobulins
  • Lamivudine
  • hepatitis B hyperimmune globulin